ArticleBMC urology2024

Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective study.

Shuaiqi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.